Journal • Tumor mutational burden • PD(L)-1 Biomarker • Metastases
|
PIK3CA (Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha) • TMB (Tumor Mutational Burden) • HRD (Homologous Recombination Deficiency) • TP53BP1 (Tumor Protein P53 Binding Protein 1)
|
HRD
|
Keytruda (pembrolizumab) • cisplatin • albumin-bound paclitaxel • sapanisertib (CB-228) • serabelisib (MLN1117)